29-Sep-17 According to the Registrar General of India, coronary heart disease is currently the cause of 32% of total adult deaths and cardiovascular diseases will be the largest cause of death and disability in India by 2020. [image: ET Healthworld]

28-Sep-17 In Jun-17 Myanmar relaxed prohibitions on foreign trading, allowing 100% foreign-owned companies to sell certain hospital equipment. Myanmar needs to be less reliant on offshore manufacturing. With the increase in private medical insurance, opportunities abound for investors. [image: The Myanmar Times]

28-Sep-17 According to the Korean government's biotechnology development plan, the government will increase the number of new drug candidates by 100 to 185 in 2026 and help companies come up with at least five new blockbuster drugs. [image: Business Korea]

20-Sep-17 MedAnt, a ground-breaking new patient information sharing app has launched on the WeChat platform in China, focusing mainly on oncology and ophthalmology. MedAnt is a social app where patients share experiences via paid Q&A and free group chats. [image: Weixin]

27-Sep-17 Livanova and MicroPort Scientific have announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management obtained approval for its family of Rega pacemakers, from the China Food & Drug Administration. [image: Shine]